New Tick-Borne Pathogen Discovered in China: Scientists Identify Asian Longhorned Tick Nairovirus (ALTNV)

JAKARTA/BEIJING — In a significant development for global virology and public health, a team of researchers in China has successfully identified and characterized a novel virus transmitted by ticks. The newly discovered pathogen, classified within the Orthonairovirus genus, has been named the Asian longhorned tick nairovirus (ALTNV).

The finding comes at a time when vector-borne diseases are increasingly drawing the attention of international health bodies, including the World Health Organization (WHO), due to climate change, shifting ecological habitats, and expanding human-wildlife interfaces. Published in the prestigious New England Journal of Medicine (NEJM), the discovery sheds light on previously unexplained cases of tick-borne illnesses in China and raises new questions regarding regional and global biosurveillance.

1. Main Facts: Understanding the Asian Longhorned Tick Nairovirus

The identification of ALTNV marks another milestone in the ongoing monitoring of tick-borne pathogens across Asia. Led by scientists from the State Key Laboratory of Pathogen and Biosecurity in Beijing, the research outlines a comprehensive profile of the virus, its vectors, its clinical manifestations, and its potential to cause severe health complications, particularly when interacting with other pathogens.

Clinical Presentation and Symptoms

Patients infected with ALTNV typically present with a constellation of symptoms that closely mimic severe influenza. These include:

• High fever
• Profound fatigue and weakness
• Gastrointestinal disturbances (such as nausea, vomiting, or diarrhea)
• Abnormal laboratory findings, notably thrombocytopenia (low blood platelet count) and elevated liver enzymes (aminotransferases), which indicate potential hepatic inflammation or tissue stress.

Despite these alarming symptoms, patients infected exclusively with ALTNV in the study cohort experienced a favorable prognosis, with all monoinfected patients achieving full recovery. However, the clinical picture changes dramatically when a patient is simultaneously infected with another well-known tick-borne virus, the Dabie bandavirus (DBV).

The Danger of Co-Infection

DBV is the causative agent of Severe Fever with Thrombocytopenia Syndrome (SFTS), a hazardous condition recognized for its high fatality rate, typically ranging between 10% and 30%. The WHO has long prioritized DBV for research due to its epidemic potential.

When researchers evaluated patients suffering from co-infections of both ALTNV and DBV, the clinical outcomes were significantly worse:

• Respiratory complications: Present in 61% of co-infected patients compared to 38% of those infected with DBV alone.
• Renal dysfunction: Observed in 84% of co-infected individuals versus 66% in DBV-only cases.
• Mortality rate: Among 38 co-infected patients tracked in the study, 7 succumbed to the illness, resulting in a fatality rate of 18.4%.

2. Chronology: How the Discovery Unfolded

The path to discovering ALTNV began not with a random ecological sweep, but with a lingering medical mystery in clinical diagnostics.

Step 1: Investigating Diagnostic Discrepancies

The research originated from an epidemiological conundrum: approximately 30% of patients presenting with clinical signs and symptoms characteristic of Dabie bandavirus (DBV) consistently tested negative for the pathogen when evaluated for tick-borne hemorrhagic fevers. This diagnostic gap baffled clinicians and prompted researchers to investigate whether another, unrecognized pathogen was circulating in these endemic regions.

Step 2: Sample Collection and Isolation

To uncover the hidden culprit, the research team gathered biological samples from patients presenting with a history of tick bites at various sentinel hospitals located across Chinese provinces known for high burdens of tick-borne diseases. Using advanced molecular techniques—specifically RNA sequencing and virus isolation—the team successfully isolated the novel viral agent from clinical specimens.

Step 3: Phylogenetic and Microscopic Characterization

Subsequent phylogenetic and genomic analyses revealed that the newly isolated virus belonged to the Orthonairovirus genus within the Nairoviridae family. Genetic sequencing indicated that the virus shared less than 80% amino acid sequence identity with other known species in the same genus, confirming its status as a distinct, novel species.

Further validation was achieved by testing human serum samples that tested positive for ALTNV RNA. Researchers successfully cultured the virus and verified its identity through immunofluorescence assays using viral antigens. Microscopic examination via electron microscopy confirmed classic orthonairovirus morphology, while cellular replication studies demonstrated the virus’s ability to multiply across various tested cell lines.

3. Supporting Data and Epidemiological Findings

To understand the prevalence and distribution of ALTNV, the research team conducted a massive surveillance sweep across China’s vector populations and patient demographics.

Patient Prevalence Rates

Out of a total of 3,163 patients evaluated during the study:

• 10.4% tested positive for ALTNV based on RNA detection or the presence of immunoglobulin M (IgM) antibodies.
• Among the subset of patients who tested negative for DBV, an astonishing 15.1% were found to be positive for ALTNV, neatly explaining a significant portion of the previously unresolved clinical cases.

Vector Distribution and Animal Reservoirs

Ticks were collected extensively across 15 provinces in China to map out environmental risks:

• Out of 47,428 ticks analyzed, viral RNA of ALTNV was detected in 1.3% of the total pool.
• The highest prevalence was discovered in the Haemaphysalis longicornis (Asian longhorned tick) species, where the infection rate reached 1.8%.
• Laboratory transmission experiments confirmed that H. longicornis is fully capable of vectoring the virus, successfully transmitting ALTNV to animal models (mice).

4. Official Responses and Scientific Implications

The publication of the study in the New England Journal of Medicine has elicited strong reactions from the global infectious disease community, prompting calls for updated diagnostic protocols and enhanced epidemiological surveillance.

Upgrading Diagnostic Capacities

Because ALTNV and DBV share overlapping geographical distributions and utilize the same primary tick vectors—most notably the Haemaphysalis longicornis tick—clinicians operating in SFTS-endemic areas face a complex diagnostic challenge.

Public health experts emphasize that standard screening protocols in these regions must be updated. Misdiagnosing a co-infection or mistaking an ALTNV infection for a milder viral illness could lead to delayed supportive care, particularly given the elevated risks of renal and respiratory complications during dual infections.

The Role of Haemaphysalis longicornis

The identification of H. longicornis as a primary vector carries international implications. This specific tick species is not restricted to China; it has demonstrated an alarming capacity to expand its geographic range globally, including establishing populations in other parts of Asia, Oceania, and North America.

Entomologists and vector-control specialists warn that the adaptability and hardiness of H. longicornis mean that pathogens it carries—including ALTNV—pose potential cross-border biosecurity considerations if unchecked by robust environmental and agricultural surveillance.

5. Broader Implications for Global Public Health

The discovery of the Asian longhorned tick nairovirus underscores a broader, concerning trend in modern medicine: the steady emergence and re-emergence of zoonotic tick-borne pathogens. As ecosystems undergo rapid transformations due to human encroachment, deforestation, and climate shifts, the contact zones between humans, wildlife, and vectors expand exponentially.

Toward a One Health Approach

Public health organizations continue to advocate for a "One Health" framework—an integrated, collaborative approach that recognizes the interconnection between human health, animal health, and the environment. Addressing novel threats like ALTNV requires coordinated efforts among:

1. Virologists and Clinicians: To rapidly identify, sequence, and treat emerging infections.
2. Entomologists: To monitor vector population densities, seasonal shifts, and geographic spread.
3. Veterinarians and Ecologists: To identify animal reservoirs and mitigate environmental transmission risks before spillover events occur on a mass scale.

While ALTNV monoinfections currently present with manageable clinical outcomes that resolve with standard supportive care, the severity associated with DBV co-infections serves as a stark reminder of the unpredictable nature of viral evolution. Continued research, heightened clinical awareness, and proactive vector management will remain the frontline defenses against the silent threat circulating in the tick populations of Asia and beyond.